Baltimore Sues Tobacco Companies Over Cigarette Litter Costs

Nov.23.2022
Baltimore Sues Tobacco Companies Over Cigarette Litter Costs
Baltimore city sues major tobacco companies for not properly disposing of cigarette waste. $5 million annually requested.

The city of Baltimore is suing several major tobacco companies, demanding up to $5 million per year to fund the cleaning of cigarette butt litter.


City government officials stated that over 12 million cigarette butts have been cleaned up from the waters surrounding Baltimore since 2014.


James Shea, a lawyer in Baltimore, stated that there are various cleaning issues, ranging from picking up cigarette butts to removing the chemicals they leave behind.


The lawsuit alleges that tobacco companies have refused to place warning labels on packaging on how to properly dispose of cigarette filters, and have chosen not to make filters biodegradable.


Shea said that based on the documents they have seen, the company did not switch to biodegradable filters because smokers prefer the suction devices that come with the filters.


Shea stated that the ultimate goal is to make these companies more environmentally friendly. "We hope to put an end to these practices, but at the same time, we want compensation for the costs of cleanup and fines related to violating various waste regulations." These companies have 30 days to respond in court.


Announcement:


This article has been compiled from third-party information and is intended for industry discussion and learning purposes only.


This article does not represent the views of 2FIRSTS, and 2FIRSTS is unable to confirm the authenticity and accuracy of the article's content. This article's compilation is solely intended for internal industry research and communication purposes.


Due to limitations in the level of translation, the translated article may not fully reflect the original text. Please refer to the original article for accuracy.


2FIRSTS maintains complete alignment with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, and foreign-related statements and positions.


The compilation of information belongs to the original media and author, and if there is any infringement, please contact us for deletion.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Six Years of Data Show FDA Clearing PMTA Backlog
Six Years of Data Show FDA Clearing PMTA Backlog
FDA data from FY2020 to FY2025 show how the PMTA system for e-cigarette products evolved after an early surge of submissions created prolonged front-end delays. Millions of applications accumulated at the Acceptance stage before entering substantive review. Since 2023, the number of applications pending acceptance has declined sharply, and industry participants report shorter initial decision timelines in late 2025.
Feb.06
Cyprus customs seizes 269 packs containing cannabis and THC; Pharmacy Department flags unauthorized CBD products
Cyprus customs seizes 269 packs containing cannabis and THC; Pharmacy Department flags unauthorized CBD products
The report says an international operation across EU countries aimed at detecting illicit substances in e-cigarettes also took place in South Cyprus, where multiple e-liquid items and products containing cannabis and THC were seized. It states the operation, titled “eVAPER8,” was conducted by the International Narcotics Control Board (INCB) in November and December to identify e-cigarette liquids that may contain synthetic drugs.
Feb.09 by 2FIRSTS.ai
China’s Tobacco Regulator Moves to Introduce Credit Management Framework for E-Cigarette Manufacturers, Greater Transparency May Improve International Assessability of China’s Supply Chain
China’s Tobacco Regulator Moves to Introduce Credit Management Framework for E-Cigarette Manufacturers, Greater Transparency May Improve International Assessability of China’s Supply Chain
China’s tobacco regulator has moved to introduce a credit management framework for e-cigarette manufacturers, outlining a system that links compliance records to regulatory oversight. The proposal forms part of a broader push to institutionalize supervision and improve transparency across China’s e-cigarette supply chain.
Jan.05
PMI reshuffles U.S. footprint: Swedish Match to shut Richmond office in April; most staff may be relocated
PMI reshuffles U.S. footprint: Swedish Match to shut Richmond office in April; most staff may be relocated
Swedish Match, a unit of Philip Morris International (PMI), will close its office in Richmond, Virginia, in April 2026 and eliminate 135 positions. PMI said the move is tied to adjustments in its U.S. operating footprint.
Feb.03
Virginia asks Fourth Circuit to stay order blocking parts of its unauthorized-vape sales law
Virginia asks Fourth Circuit to stay order blocking parts of its unauthorized-vape sales law
Virginia has asked the U.S. Court of Appeals for the Fourth Circuit to stay a district court order that blocks enforcement of certain provisions of a state law restricting the sale of unauthorized vaping products. The district court held the law was preempted to the extent it enforced federal requirements under the FDCA and the Tobacco Control Act.
Jan.21 by 2FIRSTS.ai
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
At the third session of its PMTA roundtable, the FDA outlined its framework for assessing abuse liability in ENDS products, emphasizing the role of nicotine pharmacokinetics and product-specific data in APPH determinations. Small manufacturers questioned the high cost of clinical PK studies and the absence of defined numeric thresholds, while raising bridging strategies and PBPK modeling as potential alternatives.
Feb.11